tiprankstipranks
Trending News
More News >
Akero Therapeutics (AKRO)
:AKRO
US Market
Advertisement

Akero Therapeutics (AKRO) Technical Analysis

Compare
599 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
5Neutral
1Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Akero Therapeutics’s (AKRO) Moving Averages Convergence Divergence (MACD) indicator is 0.39, suggesting Akero Therapeutics is a Buy.
Akero Therapeutics’s (AKRO) 20-Day exponential moving average is 52.37, while Akero Therapeutics’s (AKRO) share price is $53.6, making it a Buy.
Akero Therapeutics’s (AKRO) 50-Day exponential moving average is 50.12, while Akero Therapeutics’s (AKRO) share price is $53.6, making it a Buy.

Akero Therapeutics (AKRO) Pivot Points

Jul 18, 2025, 06:53 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
47.71
49.21
50.49
51.99
53.27
54.77
56.05
Fibonacci
49.21
50.28
50.93
51.99
53.06
53.71
54.77
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Akero Therapeutics (AKRO) Moving Averages

Jul 18, 2025, 06:53 PM
Period
Simple
Exponential
MA5
52.33Buy
52.48Buy
MA10
51.83Buy
52.39Buy
MA20
53.15Buy
52.37Buy
MA50
49.65Buy
50.12Buy
MA100
46.05Buy
46.55Buy
MA200
39.77Buy
40.34Buy
Akero Therapeutics’s (AKRO) 10-Day exponential moving average is 52.39, while Akero Therapeutics’s (AKRO) share price is $53.6, making it a Buy.
Akero Therapeutics’s (AKRO) 100-Day exponential moving average is 46.55, while Akero Therapeutics’s (AKRO) share price is $53.6, making it a Buy.
Akero Therapeutics’s (AKRO) stock price is $53.6 and Akero Therapeutics’s (AKRO) 50-day simple moving average is 49.65, creating a Buy signal.
Akero Therapeutics’s (AKRO) stock price is $53.6 and Akero Therapeutics’s (AKRO) 100-day simple moving average is 46.05, creating a Buy signal.
Akero Therapeutics’s (AKRO) stock price is $53.6 and Akero Therapeutics’s (AKRO) 200-day simple moving average is 39.77, creating a Buy signal.

Akero Therapeutics (AKRO) Technical Indicators

Jul 18, 2025, 06:53 PM
Name
Value
Implied Action
RSI (14)
56.26
Neutral
STOCH (9,6)
71.19
Neutral
STOCHRSI (14)
36.34
Neutral
MACD (12,26)
0.39
Buy
ADX (14)
14.29
Buy
Williams %R
-51.30
Buy
CCI (14)
3.05
Neutral
ATR (14)
2.29
-
Ultimate Oscillator
49.22
Neutral
ROC
-2.62
Sell
Akero Therapeutics’s (AKRO) Relative Strength Index (RSI) is 56.26, creating a Neutral signal.
Akero Therapeutics’s (AKRO) Trend Strength Indicator (ADX) is 14.29, creating a Buy signal.
Akero Therapeutics’s (AKRO) Commodity Channel Index (CCI) is 3.05, creating a Neutral signal.
Akero Therapeutics’s (AKRO) Price Rate of Change (ROC) is -2.62, creating a Sell signal.

FAQ

Is AKRO a Buy, Hold, or Sell?
Based on AKRO’s technical indicators, AKRO is a Strong Buy.
    What is AKRO’s RSI (14)?
    AKRO’s RSI (14) is 56.26, which suggests AKRO is a Neutral.
      What is AKRO’s MACD?
      AKRO’s MACD is 0.39, which suggests AKRO is a Buy.
        What is AKRO’s 5-day moving average?
        AKRO’s 5-day moving average is 52.33, which suggests AKRO is a Buy.
          What is AKRO’s 20-day moving average?
          AKRO 20-day moving average is 53.15, which suggests AKRO is a Buy.
            What is AKRO’s 50-day moving average?
            AKRO’s 50-day moving average is 49.65, which suggests AKRO is a Buy.
              What is AKRO’s 200-day moving average?
              AKRO’s 200-day moving average is 39.77, which suggests AKRO is a Buy.
                What is AKRO’s Williams % R (14)?
                AKRO’s Williams % R (14) is -51.30, which suggests AKRO is a Buy.
                  What is AKRO’s CCI (14)?
                  AKRO’s CCI (14) is 3.05, which suggests AKRO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis